495 related articles for article (PubMed ID: 17360380)
1. Role for CD47-SIRPalpha signaling in xenograft rejection by macrophages.
Ide K; Wang H; Tahara H; Liu J; Wang X; Asahara T; Sykes M; Yang YG; Ohdan H
Proc Natl Acad Sci U S A; 2007 Mar; 104(12):5062-6. PubMed ID: 17360380
[TBL] [Abstract][Full Text] [Related]
2. Attenuation of phagocytosis of xenogeneic cells by manipulating CD47.
Wang H; VerHalen J; Madariaga ML; Xiang S; Wang S; Lan P; Oldenborg PA; Sykes M; Yang YG
Blood; 2007 Jan; 109(2):836-42. PubMed ID: 17008545
[TBL] [Abstract][Full Text] [Related]
3. The potentiating effect of hTFPI in the presence of hCD47 reduces the cytotoxicity of human macrophages.
Jung SH; Hwang JH; Kim SE; Young Kyu K; Park HC; Lee HT
Xenotransplantation; 2017 May; 24(3):. PubMed ID: 28393401
[TBL] [Abstract][Full Text] [Related]
4. Ectopic expression of murine CD47 minimizes macrophage rejection of human hepatocyte xenografts in immunodeficient mice.
Waern JM; Yuan Q; Rüdrich U; Becker PD; Schulze K; Strick-Marchand H; Huntington ND; Zacher BJ; Wursthorn K; DiSanto JP; Guzman CA; Manns MP; Ott M; Bock M
Hepatology; 2012 Oct; 56(4):1479-88. PubMed ID: 22535707
[TBL] [Abstract][Full Text] [Related]
5. Expression of recipient CD47 on rat insulinoma cell xenografts prevents macrophage-mediated rejection through SIRPα inhibitory signaling in mice.
Teraoka Y; Ide K; Morimoto H; Tahara H; Ohdan H
PLoS One; 2013; 8(3):e58359. PubMed ID: 23472187
[TBL] [Abstract][Full Text] [Related]
6. The CD47-SIRPα signalling system: its physiological roles and therapeutic application.
Murata Y; Kotani T; Ohnishi H; Matozaki T
J Biochem; 2014 Jun; 155(6):335-44. PubMed ID: 24627525
[TBL] [Abstract][Full Text] [Related]
7. The interaction between signal regulatory protein alpha (SIRPα) and CD47: structure, function, and therapeutic target.
Barclay AN; Van den Berg TK
Annu Rev Immunol; 2014; 32():25-50. PubMed ID: 24215318
[TBL] [Abstract][Full Text] [Related]
8. Soluble extracellular domains of human SIRPα and CD47 expressed in Escherichia coli enhances the phagocytosis of leukemia cells by macrophages in vitro.
Lin Y; Yan XQ; Yang F; Yang XW; Jiang X; Zhao XC; Zhu BK; Liu L; Qin HY; Liang YM; Han H
Protein Expr Purif; 2012 Sep; 85(1):109-16. PubMed ID: 22813925
[TBL] [Abstract][Full Text] [Related]
9. Human CD47 expression permits survival of porcine cells in immunodeficient mice that express SIRPα capable of binding to human CD47.
Wang C; Wang H; Ide K; Wang Y; Van Rooijen N; Ohdan H; Yang YG
Cell Transplant; 2011; 20(11-12):1915-20. PubMed ID: 21535911
[TBL] [Abstract][Full Text] [Related]
10. Loss of Cell Surface CD47 Clustering Formation and Binding Avidity to SIRPα Facilitate Apoptotic Cell Clearance by Macrophages.
Lv Z; Bian Z; Shi L; Niu S; Ha B; Tremblay A; Li L; Zhang X; Paluszynski J; Liu M; Zen K; Liu Y
J Immunol; 2015 Jul; 195(2):661-71. PubMed ID: 26085683
[TBL] [Abstract][Full Text] [Related]
11. SLAMF7 is critical for phagocytosis of haematopoietic tumour cells via Mac-1 integrin.
Chen J; Zhong MC; Guo H; Davidson D; Mishel S; Lu Y; Rhee I; Pérez-Quintero LA; Zhang S; Cruz-Munoz ME; Wu N; Vinh DC; Sinha M; Calderon V; Lowell CA; Danska JS; Veillette A
Nature; 2017 Apr; 544(7651):493-497. PubMed ID: 28424516
[TBL] [Abstract][Full Text] [Related]
12. A membrane-type surfactant protein D (SP-D) suppresses macrophage-mediated cytotoxicity in swine endothelial cells.
Jiaravuthisan P; Maeda A; Takakura C; Wang HT; Sakai R; Shabri AM; Lo PC; Matsuura R; Kodama T; Eguchi H; Okuyama H; Miyagawa S
Transpl Immunol; 2018 Apr; 47():44-48. PubMed ID: 29425774
[TBL] [Abstract][Full Text] [Related]
13. The BALB/c-specific polymorphic SIRPA enhances its affinity for human CD47, inhibiting phagocytosis against human cells to promote xenogeneic engraftment.
Iwamoto C; Takenaka K; Urata S; Yamauchi T; Shima T; Kuriyama T; Daitoku S; Saito Y; Miyamoto T; Iwasaki H; Kitabayashi I; Itoh K; Kishimoto J; Kohda D; Matozaki T; Akashi K
Exp Hematol; 2014 Mar; 42(3):163-171.e1. PubMed ID: 24269920
[TBL] [Abstract][Full Text] [Related]
14. A function-blocking CD47 antibody suppresses stem cell and EGF signaling in triple-negative breast cancer.
Kaur S; Elkahloun AG; Singh SP; Chen QR; Meerzaman DM; Song T; Manu N; Wu W; Mannan P; Garfield SH; Roberts DD
Oncotarget; 2016 Mar; 7(9):10133-52. PubMed ID: 26840086
[TBL] [Abstract][Full Text] [Related]
15. Self inhibition of phagocytosis: the affinity of 'marker of self' CD47 for SIRPalpha dictates potency of inhibition but only at low expression levels.
Tsai RK; Rodriguez PL; Discher DE
Blood Cells Mol Dis; 2010 Jun; 45(1):67-74. PubMed ID: 20299253
[TBL] [Abstract][Full Text] [Related]
16. The hybrid CL-SP-D molecule has the potential to regulate xenogeneic rejection by human neutrophils more efficiently than CD47.
Iemitsu K; Sakai R; Maeda A; Gadomska K; Kogata S; Yasufuku D; Matsui J; Masahata K; Kamiyama M; Eguchi H; Matsumura S; Kakuta Y; Nagashima H; Okuyama H; Miyagawa S
Transpl Immunol; 2024 Jun; 84():102020. PubMed ID: 38452982
[TBL] [Abstract][Full Text] [Related]
17. Functional elements on SIRPalpha IgV domain mediate cell surface binding to CD47.
Liu Y; Tong Q; Zhou Y; Lee HW; Yang JJ; Bühring HJ; Chen YT; Ha B; Chen CX; Yang Y; Zen K
J Mol Biol; 2007 Jan; 365(3):680-93. PubMed ID: 17070842
[TBL] [Abstract][Full Text] [Related]
18. CD47-SIRPα Interactions Regulate Macrophage Uptake of Plasmodium falciparum-Infected Erythrocytes and Clearance of Malaria In Vivo.
Ayi K; Lu Z; Serghides L; Ho JM; Finney C; Wang JCY; Liles WC; Kain KC
Infect Immun; 2016 Jul; 84(7):2002-2011. PubMed ID: 27091932
[TBL] [Abstract][Full Text] [Related]
19. SIRPα-CD47 Immune Checkpoint Blockade in Anticancer Therapy.
Veillette A; Chen J
Trends Immunol; 2018 Mar; 39(3):173-184. PubMed ID: 29336991
[TBL] [Abstract][Full Text] [Related]
20. Novel SIRPα Antibodies That Induce Single-Agent Phagocytosis of Tumor Cells while Preserving T Cells.
Andrejeva G; Capoccia BJ; Hiebsch RR; Donio MJ; Darwech IM; Puro RJ; Pereira DS
J Immunol; 2021 Feb; 206(4):712-721. PubMed ID: 33431660
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
